| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 5e-13 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.06 |